Literature DB >> 10408853

Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer.

X Wu1, B Kemp, C I Amos, S E Honn, W Zhang, G L Walsh, M R Spitz.   

Abstract

Genomic instability is a driving force for tumorigenesis. p53 and telomerase play central roles in maintaining genomic integrity. The purpose of this study was to assess the associations among p53 protein overexpression, telomerase activity and genetic instability in lung cancer. We found that telomerase activity was detectable in 80% of 100 lung tumours, but only 7.7% of 91 paired adjacent normal tissues. p53 protein was overexpressed in 63% of the tumours but only 2% of the normal tissues. p53 was overexpressed in 56 of the 80 (70%) tumour tissues with telomerase activity but only seven of the 20 (35%) without telomerase activity. p53 protein overexpression carried a 6.7-fold (95% confidence interval, 1.7-27.7) increased risk for positive telomerase activity after adjustment by age, sex, ethnicity, smoking status and family history of lung cancer. The mean in vitro bleomycin-induced breaks per cell (a marker of cancer susceptibility) was significantly higher (0.92) for patients who overexpressed p53 in lung tumour tissue than that for patients with no detectable p53 expression in lung tumour tissue (0.65). Our data suggest that p53 protein overexpression may be common in individuals genetically susceptible to carcinogen exposure. p53 status may be related to telomerase expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408853      PMCID: PMC2362338          DOI: 10.1038/sj.bjc.6690378

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  Mutagen sensitivity exhibits a dose-response relationship in case-control studies.

Authors:  X Wu; T C Hsu; M R Spitz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-07       Impact factor: 4.254

3.  Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis.

Authors:  T C Hsu; D A Johnston; L M Cherry; D Ramkissoon; S P Schantz; J M Jessup; R J Winn; L Shirley; C Furlong
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

4.  New link found between p53 and DNA repair.

Authors:  J Marx
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

5.  A role for both RB and p53 in the regulation of human cellular senescence.

Authors:  J W Shay; O M Pereira-Smith; W E Wright
Journal:  Exp Cell Res       Date:  1991-09       Impact factor: 3.905

6.  Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb.

Authors:  K Hiyama; S Ishioka; Y Shirotani; K Inai; E Hiyama; I Murakami; T Isobe; T Inamizu; M Yamakido
Journal:  Oncogene       Date:  1995-03-02       Impact factor: 9.867

7.  Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

Authors:  M F Denissenko; A Pao; M Tang; G P Pfeifer
Journal:  Science       Date:  1996-10-18       Impact factor: 47.728

Review 8.  Telomeres and telomerase in aging and cancer.

Authors:  C B Harley; B Villeponteau
Journal:  Curr Opin Genet Dev       Date:  1995-04       Impact factor: 5.578

9.  Telomerase activity in small-cell and non-small-cell lung cancers.

Authors:  K Hiyama; E Hiyama; S Ishioka; M Yamakido; K Inai; A F Gazdar; M A Piatyszek; J W Shay
Journal:  J Natl Cancer Inst       Date:  1995-06-21       Impact factor: 13.506

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  4 in total

1.  Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells.

Authors:  D Xu; N Popov; M Hou; Q Wang; M Björkholm; A Gruber; A R Menkel; M Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Mutagen sensitivity and p53 expression in colorectal cancer in China.

Authors:  L Shao; M Lai; Q Huang
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

3.  Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population.

Authors:  Xianli He; Qing Qiao; Naijian Ge; Jing Nan; Shuqun Shen; Zizhong Wang; Yefa Yang; Guoqiang Bao
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

Review 4.  Telomerase as a Cancer Target. Development of New Molecules.

Authors:  D L Mengual Gomez; R G Armando; C S Cerrudo; P D Ghiringhelli; D E Gomez
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.